Teva has launched a digitally-enabled inhaler in the UK, the first European market for the device, for use by patients with asthma and chronic obstructive pulmonary disorder (COPD). The GoResp ...
GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...
Correspondence to Dr Anna Claire Murphy, Pharmacy/Respiratory Medicine, University Hospitals of Leicester NHS Trust, Leicester LE3 9QP, UK; anna.murphy{at}uhl-tr.nhs.uk We know that there is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results